Centene Corporation (CNC)
Holding Pattern Continues; CNC, BAH Post Big Beats
We don't expect much directional impetus in the stock market until after the presidential election is decided.
Centene (CNC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Centene (CNC) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Centene (CNC) Q3 Earnings and Revenues Beat Estimates
Centene (CNC) came out with quarterly earnings of $1.62 per share, beating the Zacks Consensus Estimate of $1.39 per share. This compares to earnings of $2 per share a year ago.
Centene Says It Is Positioned To Capture Long-Term Growth In Government-Sponsored Healthcare, Lifts Annual Outlook
On Friday, Centene Corporation CNC third-quarter sales of $42.02 billion, up 10.5% year-over-year, beating the consensus of $37.69 billion.
Centene Earnings Are Another Win for Health Insurer Stocks. What to Know.
The health insurer beat quarterly estimates for earnings and sales.
Obamacare Leads Centene To $713 Million Profit Even As Medicaid Dips
Centene reported a third quarter profit of $713 million as Obamacare enrollment and premium revenue helped overcome a big dip in Medicaid enrollment.
Centene's stock soars 14% after earnings sweep past estimates and company backs guidance
Chief Executive Sarah M. London said the company had navigated a ‘dynamic landscape' in the quarter amid turmoil in the Medicaid business.
Centene beats quarterly profit estimates on commercial plan strength
Centene beat Wall Street estimates for third-quarter profit on Friday, as strength in its commercial insurance business outweighed the impact of high costs related to its government-backed Medicaid plans for low-income people.
Harris trades: These healthcare stocks could rally if she wins — or drop if Trump triumphs
Certain healthcare stocks rank among the “Harris trades,” meaning stocks that could rally on a win by Democratic presidential nominee Kamala Harris. Meanwhile, small-cap banks are among the stocks that could benefit from a second Trump presidency.
Should You Buy or Sell Centene Stock Before Q3 Earnings Report?
CNC's third-quarter earnings are likely to have been affected by lower premiums and rising medical costs.
Centene: Should Have Followed My Original Thesis, But A Buy For Q3 2024
Centene, a leading health insurer, shows strong fundamentals and growth despite sector challenges, making it a "Buy" at a target price of $70/share. The company's 2Q24 results indicate robust earnings growth and increasing membership, contrasting with peers like Humana, which face significant declines. Centene's valuation at $61/share with a P/E of 9x is attractive, projecting a potential 27.17% annualized upside until 2026.
Unveiling Centene (CNC) Q3 Outlook: Wall Street Estimates for Key Metrics
Get a deeper insight into the potential performance of Centene (CNC) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
